<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17" class="ref">
 <div publication-type="journal" class="mixed-citation" xmlns="http://www.w3.org/1999/xhtml">
  <person-group person-group-type="author" class="person-group" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Gobin</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">S. J.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Peijnenburg</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">A.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Keijsers</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">V.</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Van den Elsen</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">P. J.</span>
   </name>
  </person-group> (
  <span class="year">1997</span>). 
  <div class="article-title">Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA</div>. 
  <div class="source">Immunity</div>
  <span class="volume">6</span>, 
  <span class="fpage">601</span>â€“
  <span class="lpage">611</span>
  <span pub-id-type="doi" class="pub-id">10.1016/S1074-7613(00)80348-9</span>
  <span pub-id-type="pmid" class="pub-id">9175838</span>
 </div>
</ref>
